T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 72 filers reported holding T2 BIOSYSTEMS INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,000 | -33.3% | 16,872 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $3,000 | -66.7% | 16,872 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $9,000 | 0.0% | 16,872 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $9,000 | -40.0% | 16,872 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $15,000 | -25.0% | 16,872 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $20,000 | -25.9% | 16,872 | 0.0% | 0.00% | -40.0% |
Q1 2021 | $27,000 | +28.6% | 16,872 | +1.8% | 0.01% | +25.0% |
Q4 2020 | $21,000 | -58.0% | 16,572 | -54.7% | 0.00% | -63.6% |
Q3 2020 | $50,000 | +8.7% | 36,572 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $46,000 | +119.0% | 36,572 | +10.8% | 0.01% | +83.3% |
Q1 2020 | $21,000 | -46.2% | 33,000 | 0.0% | 0.01% | -33.3% |
Q4 2019 | $39,000 | -61.4% | 33,000 | -18.6% | 0.01% | -67.9% |
Q3 2019 | $101,000 | +98.0% | 40,550 | +32.7% | 0.03% | +100.0% |
Q2 2019 | $51,000 | -36.2% | 30,550 | 0.0% | 0.01% | -41.7% |
Q1 2019 | $80,000 | +29.0% | 30,550 | +48.7% | 0.02% | +14.3% |
Q4 2018 | $62,000 | -59.5% | 20,550 | 0.0% | 0.02% | -59.6% |
Q3 2018 | $153,000 | – | 20,550 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 1,875,524 | $9,865,000 | 11.71% |
Aisling Capital LLC | 2,830,992 | $14,891,000 | 3.46% |
Flagship Pioneering Inc. | 1,950,583 | $10,260,000 | 3.34% |
Lagoda Investment Management, L.P. | 1,733,083 | $9,116,000 | 3.13% |
TIGER MANAGEMENT L.L.C. | 1,364,085 | $7,175,000 | 1.30% |
Senvest Management, LLC | 2,164,233 | $11,384,000 | 0.81% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 78,606 | $413,000 | 0.07% |
WOODSTOCK CORP | 31,014 | $163,000 | 0.03% |
Point72 Asset Management, L.P. | 367,009 | $1,930,000 | 0.01% |
GOLDMAN SACHS GROUP INC | 4,252,616 | $22,369,000 | 0.01% |